Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

50.200
+4.60010.09%
Volume:13.48M
Turnover:655.49M
Market Cap:333.18B
PE:36.42
High:50.400
Open:46.080
Low:45.380
Close:45.600
52wk High:94.869
52wk Low:43.020
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:5.00
T/O Rate:5.22%
Dividend:0.23
Dividend Rate:0.47%
EPS(LYR):1.378
ROE:12.46%
ROA:7.02%
PB:4.42
PE(LYR):36.42
PS:9.11

Loading ...

Hengrui Pharmaceuticals Completes Share Buyback Totaling 13.75 Million A-Shares

Stock News
·
Jul 19

Hengrui Pharma Executes Share Buyback, Spending Over 15 Million Yuan on July 17

Stock News
·
Jul 17

Hengrui Pharma Gets China Clinical Trial Nod for Osteoarthritis Injection; Shares Fall 4%

MT Newswires Live
·
Jul 17

Movement Alert|Hengrui Medicine Falls 3.19% in Regular Trading, Pharmaceutical Sector Broadly Weak Despite Pipeline Progress

Market Focus
·
Jul 17

AH Share Premium and Deviation Analysis for July 16th

Stock News
·
Jul 16

Hengrui Pharmaceuticals Gets Nod for Atopic Dermatitis Drug Testing

MT Newswires Live
·
Jul 16

Hengrui Pharma's HRS-8797 Tablet Receives Clinical Trial Approval Notification

Stock News
·
Jul 15

AH Share Premium and Deviation Data as of July 15th

Stock News
·
Jul 15

Movement Alert|Hengrui Medicine Rises 3.17% in Regular Trading, Pipeline Catalysts and Sector Recovery Drive Rebound

Market Focus
·
Jul 15

Mingyu Pharma, Led by Hengrui Veteran, Files for Hong Kong IPO Amid Fierce Market Competition

Deep News
·
Jul 15

Movement Alert|Hengrui Medicine Falls 3.05% in Regular Trading, FDA Issues Third Complete Response Letter for PD-1 Combination Therapy

Market Focus
·
Jul 14

Hengrui Pharmaceuticals Gets China Nod For Lupus, Arthritis Drug Trials

MT Newswires Live
·
Jul 14

Hengrui Pharma's HRS-7058 Capsule Designated as Breakthrough Therapy

Stock News
·
Jul 13

Hengrui Pharma's FXI Antibody SHR-2004 Unveils Pivotal Phase III Data at ISTH 2026 LBA Session

Deep News
·
Jul 13

AH Share Premium and Deviation Rankings as of July 13th Close

Stock News
·
Jul 13

Hengrui Pharma's Key Drug Iohexol Injection Added to National Essential Medicines List

Stock News
·
Jul 10

AH Share Premium and Deviation Rankings for July 10

Stock News
·
Jul 10

Hengrui Pharma Receives FDA Complete Response Letter for Camrelizumab Injection Application

Stock News
·
Jul 10

Movement Alert|Hengrui Pharma Rises 3.08% in Regular Trading, UBS Reiterates Buy Rating on Positive Weight-Loss Drug Data

Market Focus
·
Jul 10

UBS Reiterates 'Buy' on Hengrui Pharma, Citing Positive Weight-Loss Drug Data and Attractive Valuation

Stock News
·
Jul 09